开发三唑 - 稠合嘧啶衍生物作为组蛋白赖氨酸特异性脱甲基酶 1 ( LSD1 / KDM1A ) 的高效和可逆抑制剂。
关键词: AML treatment AML, acute myeloid leukemia ATRA, all-trans retinoic acid Antiproliferative ability BTK, Bruton׳s tyrosine kinase CDK, cyclin-dependent kinase CuAAC, copper-catalyzed azide-alkyne cycloadditions DABCO, triethylenediamine DCM, dichloromethane DIPEA, N,N-diisopropylethylamine DNMTs, DNA methyltransferases EA, ethyl acetate Epigenetic regulation EtOH, ethanol FAD, flavin adenine dinucleotide GSCs, glioma stem cells Histone demethylase LSD1 LSD1, histone lysine specific demethylase 1 MAO, monoamine oxidase MeOH, methanol Mercapto heterocycles PAINS, pan-assay interference compound Pyrimidine-triazole Rt, room temperature SAR, structure—activity relationship Structure–activity relationships (SARs) TCP, tranylcypromine TEA, triethylamine THF, terahydrofuran TLC, thin layer chromatography.
来 源: DOI:10.1016/j.apsb.2019.01.001 PDF(Sci-hub) PDF(Pubmed)